A “realignment” of the national hepatitis C treatment programme will conclude “within the next two weeks”, a HSE spokesperson has told the Medical Independent (MI).
Hundreds of patients who were approved for treatment – and hundreds more who were recently diagnosed with hepatitis C – now face uncertainty as to when they can access direct-acting antivirals (DAAs), which cure most cases of hepatitis C virus (HCV).
Source: medicalindependent.ie, 04/08/2017
Posted by Andy on 08/04 at 08:48 AM in
(0) Comments